The biological problem the study addresses begins with the peculiar architecture of the bovine placenta. In cattle, the synepitheliochorial placenta interposes six tissue layers between the maternal and fetal circulations, a barrier so effective that maternal immunoglobulins cannot cross it at all. Calves are therefore born agammaglobulinemic, entirely dependent on colostrum, the antibody-rich first milk, to acquire what immunologists call passive immunity. Colostrum delivers not only immunoglobulin G but also a suite of bioactive compounds that support early immune and metabolic adaptation. When this transfer fails, a condition known as failure of passive transfer, the consequences are well documented: higher rates of illness and death in the neonatal period and measurable economic losses across dairy operations. Decades of research have accordingly focused on the three classic pillars of colostrum management, namely quality, quantity, and speed of feeding, with on-farm Brix refractometry now a routine tool for judging colostrum quality in the barn.

Yet even under tightly standardized feeding protocols, calves vary widely in how efficiently they absorb immunoglobulin G from identical colostrum. This variability, described in the literature as differences in apparent absorption efficiency, suggests that factors beyond the colostrum itself shape the outcome. The intestinal absorptive process is complex: enterocytes lining the small intestine take up immunoglobulins through non-specific pinocytosis, process them intracellularly, and shuttle them across the cell into the bloodstream by transcytosis, with the neonatal Fc receptor playing a key role in protecting and transporting IgG and regulating its persistence in circulation. This absorptive capacity is fleeting, declining sharply within the first 24 to 36 hours after birth as the gut undergoes so-called intestinal closure, after which macromolecules can no longer cross the epithelium in meaningful quantities. Whatever determines how well a given calf exploits that narrow window, the Turkish team reasoned, might be worth manipulating deliberately.

Their candidate mechanism was gastrointestinal motility. The rate at which luminal contents travel through the gut governs how long colostral immunoglobulins remain in contact with the absorptive epithelium, and previous work has suggested that a slower abomasal emptying rate could prolong the availability of IgG for uptake by enterocytes and FcRn-mediated transport. Hyoscine N-butylbromide, an anticholinergic spasmolytic, reduces gastrointestinal smooth muscle activity by blocking muscarinic receptors, and veterinary evidence already supports a gastrointestinal effect in calves: in animals with experimentally induced nutritional diarrhea, a hyoscine N-butylbromide and dipyrone combination reduced fecal and fecal water output. The researchers hypothesized that a single dose given before the first colostrum feeding might slow transit just enough to enhance macromolecule absorption. They were careful to note the theoretical counter-risk, however, since pharmacologically dampening gut motility in a newborn could in principle impair luminal clearance and favor retention of bacteria and their products within the gastrointestinal tract.

The experiment took place on a single commercial dairy farm in Kırklareli, Türkiye, during April and May, under an animal ethics protocol approved by Afyon Kocatepe University. Eighteen clinically healthy Jersey calves, all born to cows in their third lactation and with no cases of dystocia recorded, were enrolled immediately after birth and before any colostrum was offered. The first twelve eligible calves were alternately allocated between a control group and a treatment group, six animals each, and six additional calves enrolled later were added to the treatment arm, yielding final groups of six controls and twelve treated calves. Treated animals received 0.4 milligrams per kilogram of body weight of hyoscine N-butylbromide intramuscularly, 15 to 30 minutes before their first colostrum meal. Controls received no pharmacological intervention. The design was deliberately narrow, restricting breed, parity, and season to minimize biological noise, though the authors acknowledge that this homogeneity came at the cost of a small and unevenly distributed sample.

Colostrum management was held constant across both groups, which is central to interpreting the results. Calves were separated from their dams before suckling and housed individually, and each received colostrum from its own dam at first milking, with only calves born to cows producing high-quality colostrum, defined as a Brix reading of at least 25 percent, included in the study. Maternal colostrum Brix values were statistically indistinguishable between groups, averaging about 29 percent in both. Every calf received colostrum totaling 10 to 12 percent of its body weight within the first six hours of life, with the first feeding, roughly 5 to 6 percent of body weight, delivered within 30 minutes of birth in all eighteen animals. The dams themselves were managed identically through the dry period, on a defined ration of straw, alfalfa hay, wheat and corn silage, and concentrate, and were vaccinated twice between days 210 and 255 of gestation against rotavirus, coronavirus, and Escherichia coli K99.

At 48 hours after birth, the differences between the groups were clear. Serum Brix values, a practical field proxy for blood immunoglobulin content, averaged 10.96 percent in treated calves versus 9.53 percent in controls, a difference the authors report as statistically significant. Direct measurement by radial immunodiffusion told the same story: serum IgG concentrations averaged 3,243 milligrams per deciliter in the treated group against 2,175 milligrams per deciliter in controls. Notably, three other serum markers did not differ. Total protein, a composite of albumin and many non-immunoglobulin proteins, was statistically similar between groups, as was gamma-glutamyl transferase, an enzyme commonly used as a qualitative indicator that colostrum was ingested, and glucose, which remained within physiological ranges in both groups. The authors interpret the unchanged glucose values as evidence that the drug did not disrupt early postnatal energy metabolism, an important consideration given colostrum’s role in thermoregulation and metabolic activation in the newborn.

The mechanistic story remains, by the authors’ own account, indirect. Because abomasal emptying and intestinal motility were not directly measured, the study cannot attribute the higher IgG concentrations to any specific gastrointestinal mechanism. A slower rate of gastric emptying could theoretically prolong the availability of colostral immunoglobulins for intestinal absorption, but effective absorption also depends on coordinated peristaltic and segmental activity, and excessive hypomotility could plausibly impair transit rather than enhance it. The parallel rise in serum Brix and serum IgG is consistent with validated use of Brix refractometry as an indirect indicator of passive transfer status, and the absence of a total protein difference is unsurprising given that composite protein measures are less sensitive to moderate shifts in immunoglobulin absorption under controlled feeding. The high GGT activities in both groups simply confirm successful colostrum intake, with biological variation among dams likely contributing to the lack of a between-group difference.

The limitations are substantial and the authors lay them out candidly. The sample of eighteen calves is small, no a priori power calculation was performed, and group allocation was neither fully randomized nor concealed, with the final six calves assigned directly to the treatment arm, raising the possibility of temporal confounding, albeit within a narrow enrollment window and uniform management conditions. Gastrointestinal tolerance and clinical safety were not evaluated against predefined endpoints, although no overt complications such as delayed meconium passage or abdominal distension were observed in treated calves. The single-farm setting and exclusive use of high-quality colostrum may not reflect the messier variability of field conditions. The researchers therefore frame their results as preliminary and call for larger, adequately powered studies with direct measurement of gastrointestinal motility and systematic clinical monitoring. If those studies confirm the effect, the implications could extend beyond dairy economics, offering a new angle on one of the oldest problems in neonatal immunology: how to help a newborn animal make the most of the single, irreplaceable antibody meal that nature allows it.

Subject of Research: Effect of hyoscine N-butylbromide on colostral immunoglobulin G absorption and passive immunity transfer in neonatal dairy calves

Article Title: Hyoscine N-butylbromide administration before colostrum feeding improves passive transfer in dairy calves

Article References: Başer, D. F., & Özsoy, A. K. (2026). Hyoscine N-butylbromide administration before colostrum feeding improves passive transfer in dairy calves. Frontiers in Veterinary Science, 13, Article 2002840. https://doi.org/10.3389/fvets.2026.2002840

Image Credits: AI Generated

DOI: 10.3389/fvets.2026.2002840

Keywords: colostrum, hyoscine N-butylbromide, immunoglobulin G, passive immunity transfer, neonatal calves, intestinal motility, dairy cattle, Brix refractometry, veterinary science, Fc receptor, gastrointestinal physiology, animal health